These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7069592)

  • 1. Antineoplastic effects of N6-(delta 2-isopentenyl)adenosine against L-1210 mouse lymphocytic leukemic cells using a polymeric delivery system.
    Chang Y; Hacker B
    J Pharm Sci; 1982 Mar; 71(3):328-31. PubMed ID: 7069592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the antitumor activity of N6-(delta 2-isopentenyl)adenosine against cultured L-1210 leukemia cells by pentostatin using a polymeric delivery system.
    Hacker B; Chang Y
    J Pharm Sci; 1983 Aug; 72(8):902-5. PubMed ID: 6604803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cytotoxicity of N6-(delta 2-isopentenyl)adenosine in combination with pentostatin against L-1210 leukemia cells.
    Hacker B; Chang Y
    J Pharm Sci; 1983 Oct; 72(10):1225-6. PubMed ID: 6606032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effects of Eleutherococcus senticosus aqueous extracts in combination with N6-(delta 2-isopentenyl)-adenosine and 1-beta-D-arabinofuranosylcytosine against L1210 leukemia cells.
    Hacker B; Medon PJ
    J Pharm Sci; 1984 Feb; 73(2):270-2. PubMed ID: 6707901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of N6-(delta2-isopentenyl)adenosine treatment in vivo on hexokinase activity of mouse L 1210 cells.
    Shavelson LJ; Tritsch GL
    J Med; 1975; 6(2):181-8. PubMed ID: 1057642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural occurrence of an inhibitor of mammalian cell growth in human and mouse cells of normal and tumor origin.
    Burns DM; Rodi CP; Agris PF
    Cancer Biochem Biophys; 1976; 1(6):269-80. PubMed ID: 1035127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal antibodies specific for isopentenyl adenosine derivatives occurring in transfer RNA.
    Woodsworth ML; Latimer LJ; Janzer JJ; McLennan BD; Lee JS
    Biochem Biophys Res Commun; 1983 Jul; 114(2):791-6. PubMed ID: 6882455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some short-chain N6-substituted adenosine analogues with antitumor properties.
    Fleysher MH; Bernacki RJ; Bullard GA
    J Med Chem; 1980 Dec; 23(12):1448-52. PubMed ID: 7452700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induced by modified ribonucleosides in human cell culture systems.
    Meisel H; Günther S; Martin D; Schlimme E
    FEBS Lett; 1998 Aug; 433(3):265-8. PubMed ID: 9744808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice.
    Ciaglia E; Pisanti S; Picardi P; Laezza C; Sosa S; Tubaro A; Vitale M; Gazzerro P; Malfitano AM; Bifulco M
    Pharmacol Res; 2014 Nov; 89():1-10. PubMed ID: 25063359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-(delta2-isopentenyl)adenosine, an inhibitor of cellular transport of uridine and cytidine.
    Hakala MT; Slocum HK; Gryko GJ
    J Cell Physiol; 1975 Oct; 86(2 Pt 1):281-91. PubMed ID: 1194366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of natural resistance to N6-(delta2-isopentenyl)adenosine in cultured cells.
    Slocum HK; Hakala MT
    Cancer Res; 1975 Feb; 35(2):423-8. PubMed ID: 162874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specificity of the chemical modification of N6-delta 2-(isopentenyl)adenosine in purified yeast tRNA Ser.
    Horváth P; Dénes G
    Biochim Biophys Acta; 1977 Jan; 474(2):188-98. PubMed ID: 318861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine levels of N-[9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, N6-(delta 2-isopentenyl)adenosine, and 2'-O-methylguanosine as determined by radioimmunoassay for normal subjects and cancer patients.
    Vold BS; Keith DE; Slavik M
    Cancer Res; 1982 Dec; 42(12):5265-9. PubMed ID: 7139629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a deficiency of N6-(delta 2-isopentenyl)-2-methylthioadenosine in the Escherichia coli mutant trpX by use of antibodies to N6-(delta 2-isopentenyl)adenosine.
    Vold BS; Lazar JM; Gray AM
    J Biol Chem; 1979 Aug; 254(15):7362-7. PubMed ID: 379002
    [No Abstract]   [Full Text] [Related]  

  • 16. N6-isopentenyladenosine a new potential anti-angiogenic compound that targets human microvascular endothelial cells in vitro.
    Castiglioni S; Romeo V; Casati S; Ottria R; Perrotta C; Ciuffreda P; Maier JAM
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(10):533-545. PubMed ID: 30465624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-6-(delta-2-isopentenyl) adenosine: hydrolysis by a mucleosidase isolated from Lactobacillus acidophilus cells.
    Hordern J; Johnson RH; McLennan BD
    Can J Microbiol; 1975 May; 21(5):633-38. PubMed ID: 236087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic-AMP content in Escherichia coli B/b as affected by N1-(delta 2-isopentyl)adenine.
    Coppola S; Zoina A; Marino P
    Zentralbl Bakteriol Naturwiss; 1978; 133(3):245-9. PubMed ID: 211751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-specific differences in the metabolism of N6-(delta2-isopentenyl)-adenosine.
    Rustum YM; Schwartz HS
    Biochem Pharmacol; 1976 Sep; 25(18):2059-65. PubMed ID: 985544
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of N6-(delta2-isopentenyl)adenine with cyclic AMP on the regulation of growth and beta-galactosidase synthesis in Escherichia coli.
    Coppola S; Zoina A; Marino P
    J Gen Microbiol; 1976 Jun; 94(2):436-8. PubMed ID: 181529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.